🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Samsung Biologics Co Ltd (207940)

Seoul
Currency in KRW
953,000
-9,000(-0.94%)
Closed
207940 Scorecard
Full Analysis
3 analysts have revised their earnings downwards for the upcoming period
Fair Value
Day's Range
941,000975,000
52 wk Range
698,0001,113,000
Key Statistics
Edit
Bid/Ask
952,000.00 / 953,000.00
Prev. Close
962,000
Open
942,000
Day's Range
941,000-975,000
52 wk Range
698,000-1,113,000
Volume
118.5K
Average Volume (3m)
95.46K
1-Year Change
36.67%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
207940 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
1,209,780.00
Upside
+26.94%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
Show more

Samsung Biologics Co Ltd Company Profile

Samsung Biologics Co.,Ltd. engages in the contract development and manufacturing organization (CDMO) business for biopharmaceuticals products in South Korea, Europe, the United States, and internationally. The company operates in two segments, CDMO, and Biopharmaceutical Development and Commercialization. Its development services include discovery, cell line development, process development, and clinical manufacturing. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and support services; and quality assurance and control, as well as biosafety and analytical testing services. In addition, it engages in the research and commercialization of biosimilar drugs; development and manufacture of antibody-drug conjugates; and manufactures mammalian and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.

Employees
4284

Compare 207940 to Peers and Sector

Metrics to compare
207940
Peers
Sector
Relationship
P/E Ratio
65.1x12.5x−0.7x
PEG Ratio
0.000.090.00
Price/Book
6.5x1.5x2.6x
Price / LTM Sales
15.7x1.8x3.2x
Upside (Analyst Target)
29.7%16.9%47.0%
Fair Value Upside
Unlock3.2%7.5%Unlock

Analysts' Recommendations

23 Buy
1 Hold
1 Sell
Ratings:
25 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 1,209,780

(+26.94% Upside)

People Also Watch

175,100
068270
-2.78%
253,500
005490
-4.52%
168,900
000660
+1.08%
387,500
373220
-0.77%
279,000
012450
-6.38%

FAQ

What Is the Samsung Biologics (207940) Stock Price Today?

The Samsung Biologics stock price today is 953,000.00

What Stock Exchange Does Samsung Biologics Trade On?

Samsung Biologics is listed and trades on the Seoul stock exchange.

What Is the Stock Symbol for Samsung Biologics?

The stock symbol for Samsung Biologics is "207940."

What Is the Samsung Biologics Market Cap?

As of today, Samsung Biologics market cap is 68.47T.

What is Samsung Biologics Earnings Per Share?

The Samsung Biologics EPS is 14,787.79.

What Is the Next Samsung Biologics Earnings Date?

Samsung Biologics will release its next earnings report on Jan 27, 2025.

From a Technical Analysis Perspective, Is 207940 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.